Celularity Inc.
CELU
$2.05
$0.010.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.74M | 11.43M | 18.13M | 9.30M | 12.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.74M | 11.43M | 18.13M | 9.30M | 12.11M |
| Cost of Revenue | 5.24M | 3.55M | 7.34M | 3.88M | 2.12M |
| Gross Profit | 494.00K | 7.87M | 10.79M | 5.41M | 9.99M |
| SG&A Expenses | 12.63M | 14.26M | 16.06M | 12.65M | 15.91M |
| Depreciation & Amortization | 372.00K | 368.00K | 376.00K | 375.00K | 456.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.60M | 21.91M | 27.61M | 20.82M | 22.29M |
| Operating Income | -15.86M | -10.49M | -9.47M | -11.53M | -10.18M |
| Income Before Tax | -24.52M | -19.75M | -13.29M | -16.10M | -6.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.52M | -19.75M | -13.29M | -16.10M | -6.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.52M | -19.75M | -13.29M | -16.10M | -6.49M |
| EBIT | -15.86M | -10.49M | -9.47M | -11.53M | -10.18M |
| EBITDA | -14.03M | -8.65M | -7.60M | -9.63M | -8.18M |
| EPS Basic | -1.02 | -0.84 | -0.60 | -0.73 | -0.30 |
| Normalized Basic EPS | -0.61 | -0.37 | -0.36 | -0.46 | -0.18 |
| EPS Diluted | -1.02 | -0.84 | -0.60 | -0.73 | -0.30 |
| Normalized Diluted EPS | -0.61 | -0.37 | -0.36 | -0.46 | -0.18 |
| Average Basic Shares Outstanding | 24.02M | 23.53M | 22.29M | 21.98M | 21.85M |
| Average Diluted Shares Outstanding | 24.02M | 23.53M | 22.29M | 21.98M | 21.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |